PEDIATRICS Vol. 86 No. 4 October 1990, pp. 564-571
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dunn, M. S.
Right arrow Articles by Possmayer, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dunn, M. S.
Right arrow Articles by Possmayer, F.

Single- Versus Multiple-Dose Surfactant Replacement Therapy in Neonates of 30 to 36 Weeks' Gestation With Respiratory Distress Syndrome

Michael S. Dunn MD, FRCPC1, Andrew T. Shennan MB, MRCP(UK), FRCPC1, and Fred Possmayer PhD1

1 From the Regional Perinatal Unit, University of Toronto Perinatal Complex, Women's College Hospital, Toronto, and University of Western Ontario, London, Ontario, Canada

To assess the efficacy of a multiple-dose protocol of surfactant replacement therapy in neonates of 30 to 36 weeks' gestation, 75 neonates were randomly assigned to control, single-dose surfactant, or multiple-dose surfactant groups. Neonates at less than 6 hours of age with a diagnosis of respiratory distress syndrome were eligible. Subjects were randomly assigned to receive either 100 mg/kg of bovine surfactant or air placebo. Neonates in the multiple-dose group were eligible to receive up to three additional doses as indicated. Neonates in both surfactant groups showed a positive response to treatment, with marked improvement in oxygenation by 10 minutes postinstillation (P < .0001). Both surfactant groups had better oxygenation than control subjects at lower ventilatory parameters over the first 24 hours. A deterioration in oxygenation and ventilatory requirements was seen in both treatment groups starting 6 to 12 hours after the first dose. The deterioration in oxygenation could be minimized by the use of multiple doses; however, extra doses had no effect on diminishing ventilatory requirements or time to extubation. It is concluded that surfactant therapy at less than 6 hours of age is effective in acutely reducing oxygen and ventilatory requirements in neonates of 30 to 36 weeks' gestation with respiratory distress syndrome. It appears that multiple doses of surfactant have a greater effect on sustaining improvements in oxygenation than on ventilatory requirements. Further study is required to determine optimal dosage and retreatment strategy.

Key Words: pulmonary surfactant • respiratory distress syndrome • neonates

Submitted on September 11, 1989
Accepted on November 7, 1989




This article has been cited by other articles:


Home page
 PediatricsHome page
W. A. Engle and and the Committee on Fetus and Newborn
Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate
Pediatrics, February 1, 2008; 121(2): 419 - 432.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
M. Ghodrat
Lung surfactants.
Am. J. Health Syst. Pharm., August 15, 2006; 63(16): 1504 - 1521.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
P. D Reiter, C. Sims, L. Harmes, J. Paisley, A. A Rosenberg, and R. J Valuck
Calfactant Sterility in Multiple Doses from Single-Use Vials
Ann. Pharmacother., September 1, 2003; 37(9): 1219 - 1223.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
L.-Y. Chien, A. Ohlsson, M. M. K. Seshia, J. Boulton, K. Sankaran, and S. K. Lee
Variations in Antenatal Corticosteroid Therapy: A Persistent Problem Despite 30 Years of Evidence
Obstet. Gynecol., March 1, 2002; 99(3): 401 - 408.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. Kattwinkel, B. T. Bloom, P. Delmore, C. Glick, D. Brown, S. Lopez, L. Willett, E. A. Egan, M. Conaway, and J. Patrie
High-Versus Low-Threshold Surfactant Retreatment For Neonatal Respiratory Distress Syndrome
Pediatrics, August 1, 2000; 106(2): 282 - 288.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. J. Novick, R. A. W. Veldhuizen, F. Possmayer, J. Lee, D. Sandler, and J. F. Lewis
Exogenous surfactant therapy in thirty-eight hour lung graft preservation for transplantation
J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 259 - 268.
[Abstract] [Full Text]

Home page
 NEJMHome page
A. H. Jobe
Pulmonary Surfactant Therapy
N. Engl. J. Med., March 25, 1993; 328(12): 861 - 868.
[Full Text]